Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis. (Q38020432)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718512%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

meta-analysis

0 references

title

Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718512%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

1 reference

1 reference

metabolic dysfunction–associated steatotic liver disease

1 reference

1 reference

traditional Chinese medicine

1 reference

inferred from title

object named as

traditional Chinese medicine

17 February 2024

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718512%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Keqing Shi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718512%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Wen-Yue Liu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718512%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Yu-Chen Fan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718512%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Ling-Fei Li

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718512%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Yong-Ping Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718512%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

21 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718512%20AND%20SRC:MED&resulttype=core&format=json

Molecular Biology Reports

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718512%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718512%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718512%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

9715-9722

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718512%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11033-012-1836-0

5 February 2020

exact match

0 references

cites work

Epidemiology of non-alcoholic fatty liver disease in China.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

Long-term follow-up of patients with nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

Current and emerging therapies in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

Rhaponticin from rhubarb rhizomes alleviates liver steatosis and improves blood glucose and lipid profiles in KK/Ay diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

Effects of traditional Chinese medicines on serum lipid profiles and homocysteine in the ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

Meta-analysis: recent developments in quantitative methods for literature reviews.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

The role of traditional Chinese herbal medicines in cancer therapy--from TCM theory to mechanistic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

Biological analysis of herbal medicines used for the treatment of liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

21 January 2018

Herbal hepatotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

Discordance between ALT values and fibrosis in liver transplant recipients treated with ribavirin for recurrent hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

Randomization, permuted blocks, masking, allocation concealment, and selection bias in the Tobacco Quit Line Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

Statistical power, sample size, and their reporting in randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

Engaging parents to increase youth physical activity a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-012-1836-0

Stress signaling in the methionine-choline-deficient model of murine fatty liver disease

21 January 2018

1 reference

12 December 2020

Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT.

1 reference

12 December 2020

Herbal hepatotoxicity

1 reference

12 December 2020

Alleviation of hepatic oxidative stress by Chinese herbal medicine Yin-Chen-Hao-Tang in obese mice with steatosis

1 reference

12 December 2020

Clinical study on treatment of non-alcoholic fatty liver of damp-heat syndrome type by danning tablet

1 reference

12 December 2020

10.1007/S11033-012-1836-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718512%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

5 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718512%20AND%20SRC:MED&resulttype=core&format=json